Congenital hypothyroidism: A newborn screening success story?

Stephen Lafranchi

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Congenital hypothyroidism, present in 1: 4000 newborns, is one of the most common preventable causes of mental retardation. Screening programs, now routine in all 50 states, Canada, and most of the developed world, have been immensely successful in detection and early treatment of affected infants. Diagnostic studies show thyroid dysgenesis to be the most common etiology worldwide, with ectopic glands accounting for the majority of dysgenetic cases. Other etiologies include hereditary defects in thyroxine synthesis, hypopituitary hypothyroidism, and transplacental passage of maternal thyrotropin receptor blocking antibodies; the latter condition is usually associated with transient hypothyroidism. Many programs report good psychometric outcomes, with IQs similar to control groups. Some, however, report slightly lower IQs, particularly in the most severely affected infants. These IQ differences may result from the effects of fetal hypothyroidism, neonatal hypothyroidism that occurs be assure proper dosing and compliance in the first 2 years is also important to neurologic outcome. The future may include screening of women of child-bearing age for hypothyroidism and some way to screen and treat the hypothyroid fetus.

Original languageEnglish (US)
Pages (from-to)477-486
Number of pages10
JournalEndocrinologist
Volume4
Issue number6
StatePublished - 1994

Fingerprint

Congenital Hypothyroidism
Hypothyroidism
Newborn Infant
Thyroid Dysgenesis
Thyrotropin Receptors
Blocking Antibodies
Thyroxine
Psychometrics
Intellectual Disability
Nervous System
Compliance
Canada
Fetus
Mothers
Control Groups

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Congenital hypothyroidism : A newborn screening success story? / Lafranchi, Stephen.

In: Endocrinologist, Vol. 4, No. 6, 1994, p. 477-486.

Research output: Contribution to journalArticle

Lafranchi, S 1994, 'Congenital hypothyroidism: A newborn screening success story?', Endocrinologist, vol. 4, no. 6, pp. 477-486.
Lafranchi, Stephen. / Congenital hypothyroidism : A newborn screening success story?. In: Endocrinologist. 1994 ; Vol. 4, No. 6. pp. 477-486.
@article{83cd05ffe36e4a5f96155a75973033c7,
title = "Congenital hypothyroidism: A newborn screening success story?",
abstract = "Congenital hypothyroidism, present in 1: 4000 newborns, is one of the most common preventable causes of mental retardation. Screening programs, now routine in all 50 states, Canada, and most of the developed world, have been immensely successful in detection and early treatment of affected infants. Diagnostic studies show thyroid dysgenesis to be the most common etiology worldwide, with ectopic glands accounting for the majority of dysgenetic cases. Other etiologies include hereditary defects in thyroxine synthesis, hypopituitary hypothyroidism, and transplacental passage of maternal thyrotropin receptor blocking antibodies; the latter condition is usually associated with transient hypothyroidism. Many programs report good psychometric outcomes, with IQs similar to control groups. Some, however, report slightly lower IQs, particularly in the most severely affected infants. These IQ differences may result from the effects of fetal hypothyroidism, neonatal hypothyroidism that occurs be assure proper dosing and compliance in the first 2 years is also important to neurologic outcome. The future may include screening of women of child-bearing age for hypothyroidism and some way to screen and treat the hypothyroid fetus.",
author = "Stephen Lafranchi",
year = "1994",
language = "English (US)",
volume = "4",
pages = "477--486",
journal = "Endocrinologist",
issn = "1051-2144",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Congenital hypothyroidism

T2 - A newborn screening success story?

AU - Lafranchi, Stephen

PY - 1994

Y1 - 1994

N2 - Congenital hypothyroidism, present in 1: 4000 newborns, is one of the most common preventable causes of mental retardation. Screening programs, now routine in all 50 states, Canada, and most of the developed world, have been immensely successful in detection and early treatment of affected infants. Diagnostic studies show thyroid dysgenesis to be the most common etiology worldwide, with ectopic glands accounting for the majority of dysgenetic cases. Other etiologies include hereditary defects in thyroxine synthesis, hypopituitary hypothyroidism, and transplacental passage of maternal thyrotropin receptor blocking antibodies; the latter condition is usually associated with transient hypothyroidism. Many programs report good psychometric outcomes, with IQs similar to control groups. Some, however, report slightly lower IQs, particularly in the most severely affected infants. These IQ differences may result from the effects of fetal hypothyroidism, neonatal hypothyroidism that occurs be assure proper dosing and compliance in the first 2 years is also important to neurologic outcome. The future may include screening of women of child-bearing age for hypothyroidism and some way to screen and treat the hypothyroid fetus.

AB - Congenital hypothyroidism, present in 1: 4000 newborns, is one of the most common preventable causes of mental retardation. Screening programs, now routine in all 50 states, Canada, and most of the developed world, have been immensely successful in detection and early treatment of affected infants. Diagnostic studies show thyroid dysgenesis to be the most common etiology worldwide, with ectopic glands accounting for the majority of dysgenetic cases. Other etiologies include hereditary defects in thyroxine synthesis, hypopituitary hypothyroidism, and transplacental passage of maternal thyrotropin receptor blocking antibodies; the latter condition is usually associated with transient hypothyroidism. Many programs report good psychometric outcomes, with IQs similar to control groups. Some, however, report slightly lower IQs, particularly in the most severely affected infants. These IQ differences may result from the effects of fetal hypothyroidism, neonatal hypothyroidism that occurs be assure proper dosing and compliance in the first 2 years is also important to neurologic outcome. The future may include screening of women of child-bearing age for hypothyroidism and some way to screen and treat the hypothyroid fetus.

UR - http://www.scopus.com/inward/record.url?scp=0027943132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027943132&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0027943132

VL - 4

SP - 477

EP - 486

JO - Endocrinologist

JF - Endocrinologist

SN - 1051-2144

IS - 6

ER -